163 related articles for article (PubMed ID: 16556730)
1. Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization.
Qazi AM; Tsai-Morris CH; Dufau ML
Mol Endocrinol; 2006 Aug; 20(8):1912-23. PubMed ID: 16556730
[TBL] [Abstract][Full Text] [Related]
2. Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3.
Biener E; Martin C; Daniel N; Frank SJ; Centonze VE; Herman B; Djiane J; Gertler A
Endocrinology; 2003 Aug; 144(8):3532-40. PubMed ID: 12865335
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative and cooperative effects of mutant forms of prolactin receptor.
Perrot-Applanat M; Gualillo O; Pezet A; Vincent V; Edery M; Kelly PA
Mol Endocrinol; 1997 Jul; 11(8):1020-32. PubMed ID: 9212050
[TBL] [Abstract][Full Text] [Related]
4. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
5. Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin.
Kang JH; Hassan SA; Zhao P; Tsai-Morris CH; Dufau ML
Biochim Biophys Acta; 2014 Jul; 1840(7):2272-80. PubMed ID: 24735798
[TBL] [Abstract][Full Text] [Related]
6. Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.
Xie YL; Hassan SA; Qazi AM; Tsai-Morris CH; Dufau ML
Mol Cell Biol; 2009 May; 29(10):2546-55. PubMed ID: 19273600
[TBL] [Abstract][Full Text] [Related]
7. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND
Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725
[TBL] [Abstract][Full Text] [Related]
8. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
Jabbour HN; Critchley HO; Boddy SC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
[TBL] [Abstract][Full Text] [Related]
9. Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells.
Tan D; Johnson DA; Wu W; Zeng L; Chen YH; Chen WY; Vonderhaar BK; Walker AM
Mol Endocrinol; 2005 May; 19(5):1291-303. PubMed ID: 15695371
[TBL] [Abstract][Full Text] [Related]
10. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor.
Tsunekawa B; Wada M; Ikeda M; Uchida H; Naito N; Honjo M
Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259
[TBL] [Abstract][Full Text] [Related]
11. Short form 1b human prolactin receptor down-regulates expression of the long form.
Tan D; Walker AM
J Mol Endocrinol; 2010 Mar; 44(3):187-94. PubMed ID: 19906835
[TBL] [Abstract][Full Text] [Related]
12. The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor.
Pezet A; Buteau H; Kelly PA; Edery M
Mol Cell Endocrinol; 1997 May; 129(2):199-208. PubMed ID: 9202403
[TBL] [Abstract][Full Text] [Related]
13. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
Selvaraj NG; Omi E; Gibori G; Rao MC
Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
[TBL] [Abstract][Full Text] [Related]
15. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
Kavarthapu R; Dufau ML
Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
[TBL] [Abstract][Full Text] [Related]
17. Role of tyrosine phosphorylation in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase.
Prevarskaya NB; Skryma RN; Vacher P; Daniel N; Djiane J; Dufy B
J Biol Chem; 1995 Oct; 270(41):24292-9. PubMed ID: 7592639
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
19. Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma.
Meng J; Tsai-Morris CH; Dufau ML
Cancer Res; 2004 Aug; 64(16):5677-82. PubMed ID: 15313907
[TBL] [Abstract][Full Text] [Related]
20. Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation.
Rycyzyn MA; Reilly SC; O'Malley K; Clevenger CV
Mol Endocrinol; 2000 Aug; 14(8):1175-86. PubMed ID: 10935542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
